566 related articles for article (PubMed ID: 25389366)
1. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
2. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363
[TBL] [Abstract][Full Text] [Related]
3. CYP2J2 overexpression ameliorates hyperlipidemia via increased fatty acid oxidation mediated by the AMPK pathway.
Zhang S; Chen G; Li N; Dai M; Chen C; Wang P; Tang H; Hoopes SL; Zeldin DC; Wang DW; Xu X
Obesity (Silver Spring); 2015 Jul; 23(7):1401-13. PubMed ID: 26053032
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
[TBL] [Abstract][Full Text] [Related]
5. CYP2J2 and EETs Protect against Oxidative Stress and Apoptosis in Vivo and in Vitro Following Lung Ischemia/Reperfusion.
Chen W; Zheng G; Yang S; Ping W; Fu X; Zhang N; Wang DW; Wang J
Cell Physiol Biochem; 2014; 33(6):1663-80. PubMed ID: 24903033
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.
Yang Y; Dong R; Chen Z; Hu D; Fu M; Tang Y; Wang DW; Xu X; Tu L
Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29318723
[TBL] [Abstract][Full Text] [Related]
7. Food-drug interaction: Anabolic steroids aggravate hepatic lipotoxicity and nonalcoholic fatty liver disease induced by trans fatty acids.
Santos JDB; Mendonça AAS; Sousa RC; Silva TGS; Bigonha SM; Santos EC; Gonçalves RV; Novaes RD
Food Chem Toxicol; 2018 Jun; 116(Pt B):360-368. PubMed ID: 29704577
[TBL] [Abstract][Full Text] [Related]
8. NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome.
Zhao G; Wang X; Edwards S; Dai M; Li J; Wu L; Xu R; Han J; Yuan H
Eur J Pharmacol; 2020 Aug; 881():173276. PubMed ID: 32574674
[TBL] [Abstract][Full Text] [Related]
9. Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation.
Gai Z; Visentin M; Gui T; Zhao L; Thasler WE; Häusler S; Hartling I; Cremonesi A; Hiller C; Kullak-Ublick GA
Mol Pharmacol; 2018 Aug; 94(2):802-811. PubMed ID: 29743187
[TBL] [Abstract][Full Text] [Related]
10. The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
Wang J; Jiang W
Med Sci Monit; 2020 Feb; 26():e919220. PubMed ID: 32026851
[TBL] [Abstract][Full Text] [Related]
11. Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats.
Huang X; Wang Y; Wang Y; Yang L; Wang J; Gao Y
Cell Physiol Biochem; 2018; 49(4):1646-1658. PubMed ID: 30227401
[TBL] [Abstract][Full Text] [Related]
12. CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro.
Chen W; Yang S; Ping W; Fu X; Xu Q; Wang J
Cell Physiol Biochem; 2015; 35(5):2043-54. PubMed ID: 25870948
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice.
Li R; Xu X; Chen C; Yu X; Edin ML; Degraff LM; Lee CR; Zeldin DC; Wang DW
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):68-78. PubMed ID: 23041291
[TBL] [Abstract][Full Text] [Related]
15. Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice.
Wang X; Li L; Wang H; Xiao F; Ning Q
Scand J Immunol; 2019 Sep; 90(3):e12791. PubMed ID: 31132306
[TBL] [Abstract][Full Text] [Related]
16. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.
Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC
FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548
[TBL] [Abstract][Full Text] [Related]
17. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
[TBL] [Abstract][Full Text] [Related]
18. [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].
Liu Y; Cheng F; Luo YX; Hu P; Ren H; Peng ML
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):285-290. PubMed ID: 28494548
[No Abstract] [Full Text] [Related]
19. Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK.
Du J; Zhang M; Lu J; Zhang X; Xiong Q; Xu Y; Bao Y; Jia W
Endocrine; 2016 Sep; 53(3):701-9. PubMed ID: 26994931
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice.
Chen G; Wang P; Zhao G; Xu G; Gruzdev A; Zeldin DC; Wang DW
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):63-71. PubMed ID: 21742052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
